Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 05 Apr 2023: Lynparza (Olaparib) / Imfinzi (Durvalumab) / Ovarian Cancer / AstraZeneca: Phase 3 DUO-O trial met the primary endpoint of progression-free survival AstraZeneca reported encouraging topline […]
Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 04 Apr 2023: GB5121 / Primary CNS lymphoma / Gossamer Bio: Developement discontinued following two patient deaths Following two patient deaths in the Phase 1b/2 STAR-CNS study, the […]
Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 04 Apr 2023: Keytruda / Padcev (enfortumab vedotin-ejfv) / 1L Urothelial cancer / Merck / Astellas Pharma / Seagen: US FDA granted accelerated approval for KEYNOTE-869 trial FDA […]
Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 03 Apr 2023: DB-1303 / DB-1311 / Solid Tumors / BioNTech / DualityBio: Collaboration to co-develop two antibody-drug conjugate assets BioNTech received exclusive licenses from DualityBio for two […]
